Ernexa Therapeutics, Inc. (ERNA)
4.30
+0.14
(+3.24%)
USD |
NASDAQ |
Sep 14, 10:34
Ernexa Therapeutics Shareholders Equity (Quarterly) : 3.20M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.20M |
| March 31, 2026 | 6.859M |
| December 31, 2025 | 2.401M |
| September 30, 2025 | 3.57M |
| June 30, 2025 | 4.444M |
| March 31, 2025 | -5.95M |
| December 31, 2024 | 1.701M |
| September 30, 2024 | -45.39M |
| June 30, 2024 | -8.526M |
| March 31, 2024 | -3.412M |
| December 31, 2023 | 2.233M |
| September 30, 2023 | 3.562M |
| June 30, 2023 | 3.866M |
| March 31, 2023 | 7.38M |
| December 31, 2022 | 12.11M |
| September 30, 2022 | 8.813M |
| June 30, 2022 | 14.78M |
| March 31, 2022 | 17.31M |
| December 31, 2021 | 25.50M |
| September 30, 2021 | 13.04M |
| June 30, 2021 | 35.18M |
| March 31, 2021 | -4.421M |
| December 31, 2020 | -11.58M |
| September 30, 2020 | 0.495M |
| June 30, 2020 | 1.931M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.849M |
| December 31, 2019 | 5.091M |
| September 30, 2019 | 6.345M |
| June 30, 2019 | 6.667M |
| March 31, 2019 | 6.691M |
| December 31, 2018 | 6.917M |
| September 30, 2018 | 6.896M |
| June 30, 2018 | 6.536M |
| March 31, 2018 | 5.196M |
| December 31, 2017 | 5.536M |
| September 30, 2017 | 6.058M |
| June 30, 2017 | 6.034M |
| March 31, 2017 | 5.828M |
| December 31, 2016 | 4.068M |
| September 30, 2016 | 1.794M |
| June 30, 2016 | 2.284M |
| March 31, 2016 | 3.033M |
| December 31, 2015 | 3.848M |
| September 30, 2015 | 4.78M |
| June 30, 2015 | 6.145M |
| March 31, 2015 | 8.609M |
| December 31, 2014 | 10.92M |
| September 30, 2014 | 12.61M |
| June 30, 2014 | 13.72M |
| March 31, 2014 | 8.539M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cerenome, Inc. | 5.463M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.315M |
| Total Liabilities (Quarterly) | 3.115M |
| Debt to Equity Ratio | 0.1091 |
| Current Ratio | 2.010 |
| Net Debt Paydown Yield | 6.51% |